Insider Trading

Notable insider buying and selling activity across public companies.

Tracking and analysis of reported insider transactions, including executive and director buying or selling. Insider activity can offer insight into internal confidence, valuation perceptions, and potential inflection points.

Articles

11,898 total articles

Fractyl Health CFO Acquires Shares Amid Strategic Shifts

Fractyl Health CFO Acquires Shares Amid Strategic Shifts

Fractyl Health CFO Smith Weber Lara purchased 20,000 shares at an average price of $0.6854, bringing her direct holdings to 20,000 shares. The transaction occurred as the stock traded near its 52-week low following a 16% weekly decline. Despite reporting zero revenue in Q1 2026, the company exceeded analyst expectations with an EPS of -$0.06 versus…

Impinj Director Affiliated With Sylebra Capital Offloads $5.89 Million in Shares Amid Stock Correction

Impinj Director Affiliated With Sylebra Capital Offloads $5.89 Million in Shares Amid Stock Correction

Sylebra Capital LLC, acting as an investment sub-adviser for Impinj Inc. (NASDAQ: PI) director Daniel Patrick Gibson, executed two separate sales of Impinj common stock totaling $5,890,074 on June 5, 2026. The transactions, which involved the disposal of 47,479 shares at prices ranging from $122.5003 to $128.8684, reduce Sylebra's indirect holding …

ANI Pharmaceuticals CFO Stephen Carey Executes Option Exercise and Sale Under Pre-Adopted Trading Plan

ANI Pharmaceuticals CFO Stephen Carey Executes Option Exercise and Sale Under Pre-Adopted Trading Plan

Stephen P. Carey, Senior Vice President and Chief Financial Officer at ANI Pharmaceuticals Inc. (NASDAQ:ANIP), executed a series of transactions on June 5, 2026, involving the exercise of stock options and the subsequent sale of 3,312 shares of common stock. The sale was conducted at $80.00 per share, totaling $264,960. These actions were part of a…

Starbucks Executive Brewer Liquidates Stake Under Pre-Arranged Plan

Starbucks Executive Brewer Liquidates Stake Under Pre-Arranged Plan

Brady Brewer, Starbucks' international chief executive, executed a sale of 1,641 shares under a Rule 10b5-1 plan, bringing his direct holdings to over 80,000 shares. The transaction highlights ongoing corporate activities, including a $1.32 billion note tender offer and strategic shifts in compensation tied to AI adoption, set against a backdrop of…

Sunrun CFO Executes Stock Sale Amid Post-Earnings Volatility

Sunrun CFO Executes Stock Sale Amid Post-Earnings Volatility

Sunrun Inc. (NASDAQ: RUN) CFO Danny Abajian sold 2,030 shares on June 8, 2026, for $27,189 to cover tax obligations from vested restricted stock units. The transaction occurred as the stock declined 17% over the past week despite a 52% annual return. Abajian also managed indirect holdings through a family trust. Sunrun recently reported Q1 2026 EPS…

Boyd Gaming Insider Activity and Market Developments

Boyd Gaming Insider Activity and Market Developments

Uri Clinton, Chief Legal Officer and Secretary of Boyd Gaming Corp. (NASDAQ: BYD), executed a sale of 3,468 shares on June 9, 2026, valued at $304,108. The transaction occurred at $87.69 per share, leaving Clinton with a direct holding of 56,818 shares. This insider activity coincides with the company trading near its 52-week high of $89.96, despit…

Axos Financial Executive Constantine Disposes of $176,574 in Stock

Axos Financial Executive Constantine Disposes of $176,574 in Stock

Thomas M. Constantine, Executive Vice President and Chief Credit Officer at Axos Financial, Inc. (NASDAQ: AX), executed a sale of 1,994 shares of the company's common stock on June 8, 2026. The transaction, valued at $176,574, occurred at prices ranging from $88.19 to $90.00 per share, with a weighted average price of $88.553. This sale brings Cons…

United Therapeutics CFO Executes Pre-Arranged Sale of 10,000 Shares

United Therapeutics CFO Executes Pre-Arranged Sale of 10,000 Shares

United Therapeutics Corp (NASDAQ:UTHR) Chief Financial Officer and Treasurer James Edgemond executed a transaction involving the sale of 10,000 shares of the company's common stock on June 8, 2026. The sale, valued at approximately $5.48 million, was conducted pursuant to a pre-arranged Rule 10b5-1 trading plan established on October 31, 2025. Prio…